IRADIMED CORPORATION (NASDAQ:IRMD) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k
-
0

IRADIMED CORPORATION (NASDAQ:IRMD) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

The information in Item 7.01 on this Form8-K with respect to the full year and fourth quarter 2017 is hereby incorporated by reference.

Item 7.01 Regulation FD Disclosure.

On January22, 2018,IRADIMED CORPORATION (the “Company”) issued a press release announcing its full year and first quarter 2018 financial guidance and its revenue estimates for the full year and fourth quarter 2017. The full text of the press release is included in Exhibit99.1 to this report.

The information in this Item 2.02 and 7.01 and the exhibit attached hereto shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1

Press release dated January22, 2018.


IRADIMED CORP Exhibit
EX-99.1 2 a18-3549_1ex99d1.htm EX-99.1 Exhibit 99.1     IRADIMED CORPORATION Announces 2018 Annual and First Quarter Financial Guidance   ·                  Announces Preliminary Full Year and Fourth Quarter 2017 Revenue ·                  Announces Fourth Quarter 2017 Financial Results Conference Call Date   Winter Springs,…
To view the full exhibit click here

About IRADIMED CORPORATION (NASDAQ:IRMD)

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.